Adagene Inc. — Investor Relations & Filings

Adagene Inc. is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based immunotherapies. The company's core technology is built upon its understanding of protein folding and molecular motion to create a dynamic, multi-purpose antibody discovery engine. This platform utilizes precision engineering to identify and select antibody candidates with novel mechanisms of action, primarily for oncology applications. Adagene is advancing a proprietary pipeline of therapeutic assets and also leverages its technology through strategic collaborations with other biopharmaceutical companies to address challenging targets in cancer treatment.